Skip to Content

Notice

CDC Advisory Committee on HIV and STD Prevention: Meeting.

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting.

Name: CDC Advisory Committee on HIV and STD Prevention.

Time and Date: 8:30 a.m.-5 p.m., May 30, 2002.

Place: Capital Hilton, 1001 16th Street, Washington, DC 20036, Phone: (202) 393-1000.

Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people.

Purpose: This Committee is charged with advising the Secretary and the Director, CDC, regarding objectives, strategies, and priorities for HIV and STD prevention efforts including maintaining surveillance of HIV infection, AIDS, and STDs, the epidemiologic and laboratory study of HIV/AIDS and STDs; information/education and risk reduction activities designed to prevent the spread of HIV and STDs; and other preventive measures that become available.

Matters To Be Discussed: Agenda items include issues pertaining to (1) STD/HIV program integration collaboration between CDC/HRSA, (2) Global AIDS Program, and (3) DHHS HIV/AIDS Review. Agenda items are subject to change as priorities dictate.

Start Further Info

FOR MORE INFORMATION CONTACT:

Paulette Ford-Knights, Public Health Analyst, National Center for HIV, STD, and TB Prevention, 1600 Clifton Road, NE, Mailstop E-07, Atlanta, Georgia 30333. Telephone 404/639-8008, fax 404/639-3125, e-mail pbf7@cdc.gov.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Dated: April 18, 2002.

Alvin Hall,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

End Signature End Further Info End Preamble

[FR Doc. 02-10131 Filed 4-24-02; 8:45 am]

BILLING CODE 4163-18-P